These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 35093242)
1. Is Omicron the last SARS-CoV-2 Variant of Concern? Rahimi F; Talebi Bezmin Abadi A Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242 [TBL] [Abstract][Full Text] [Related]
2. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates. Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140 [TBL] [Abstract][Full Text] [Related]
3. Has Omicron Changed the Evolution of the Pandemic? Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638 [TBL] [Abstract][Full Text] [Related]
4. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022. Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547 [TBL] [Abstract][Full Text] [Related]
5. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. Wang L; Cheng G J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752 [TBL] [Abstract][Full Text] [Related]
6. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. Dhama K; Nainu F; Frediansyah A; Yatoo MI; Mohapatra RK; Chakraborty S; Zhou H; Islam MR; Mamada SS; Kusuma HI; Rabaan AA; Alhumaid S; Mutair AA; Iqhrammullah M; Al-Tawfiq JA; Mohaini MA; Alsalman AJ; Tuli HS; Chakraborty C; Harapan H J Infect Public Health; 2023 Jan; 16(1):4-14. PubMed ID: 36446204 [TBL] [Abstract][Full Text] [Related]
7. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant? Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Omicron variant: Why global communities should take it seriously? Rahmani S; Rezaei N Immun Inflamm Dis; 2022 May; 10(5):e618. PubMed ID: 35478443 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021. CDC COVID-19 Response Team MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670 [TBL] [Abstract][Full Text] [Related]
11. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Meo SA; Meo AS; Al-Jassir FF; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465 [TBL] [Abstract][Full Text] [Related]
12. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City. Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235 [TBL] [Abstract][Full Text] [Related]
14. The Deltacron conundrum: Its origin and potential health risks. Farheen S; Araf Y; Tang YD; Zheng C J Med Virol; 2022 Nov; 94(11):5096-5102. PubMed ID: 35815524 [TBL] [Abstract][Full Text] [Related]
15. An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant. Rathinasamy M; Kandhasamy S J Med Virol; 2022 Jun; 94(6):2414-2421. PubMed ID: 35112734 [TBL] [Abstract][Full Text] [Related]
16. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Kannan S; Shaik Syed Ali P; Sheeza A Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466 [TBL] [Abstract][Full Text] [Related]
17. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic. Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226 [TBL] [Abstract][Full Text] [Related]
18. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa. Yu Y; Yu Y; Zhao S; He D Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998 [TBL] [Abstract][Full Text] [Related]
19. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related]
20. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks. Akaishi T; Ishii T J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]